ALDACTONE Side Effects

7022599-1 | Orthostatic Hypotension, Paraesthesia, Renal Failure Chronic, Syncope
on Sep 22, 2010 Male patient from SWITZERLAND , 75 years of age, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: orthostatic hypotension, paraesthesia, renal failure chronic, syncope. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with LASIX (125 Mg, 2x/day) (View Lasix Review and Lasix Label ), TOREM (1 Df, 1x/day) (View Torem Review and Torem Label ), MARCUMAR (1 Df, As Needed) (View Marcumar Review and Marcumar Label ), CORDARONE (200 Mg, 1x/day) (View Cordarone Review and Cordarone Label ), SIMVASTATIN (20 Mg, 1x/day) (View Simvastatin Review and Simvastatin Label ), METOPROLOL SUCCINATE (25 Mg, 2x/day) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), COZAAR (50 Mg, 1x/day) (View Cozaar Review and Cozaar Label ), SERTRALINE (1 Df, 1x/day) (View Sertraline Review and Sertraline Label ). Patient was hospitalized.

7002434-8 | Colitis Ischaemic, Fatigue, Hyperhidrosis, Hypotension, Intestinal Ischaemia, Nausea, Tinnitus
Patient was taking Aldactone (View Usage). Patient had the following side effects: colitis ischaemic, fatigue, hyperhidrosis, hypotension, intestinal ischaemia, nausea (What is nausea?), tinnitus (What is tinnitus?) on Sep 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 128.3 lb, was diagnosed with meniere's disease (What is meniere's disease?) and. Aldactone dosage: 25mg 1 A Day. Patient was hospitalized and became disabled.

7001674-1 | Confusional State, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Sep 10, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 50 Mg, 1x/day) . Location: FRANCE , 65 years of age, After Aldactone was administered, patient had the following side effects: confusional state, hyponatraemia, inappropriate antidiuretic hormone secretion. During the same period patient was treated with OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), METFORMIN (1000 Mg, Unk) (View Metformin Review and Metformin Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ZOCOR (View Zocor Review and Zocor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ). Patient was hospitalized.

7001661-3 | Blood Potassium Decreased, Hypoaesthesia, Pain In Extremity, Paraesthesia
on Sep 08, 2010 Male patient from UNITED STATES , weighting 209.4 lb, was diagnosed with hypertension, diabetes mellitus and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, hypoaesthesia, pain in extremity, paraesthesia. Aldactone dosage: 100 Mg, 2x/day. During the same period patient was treated with METFORMIN (Unk) (View Metformin Review and Metformin Label ).


6991859-2 | Gastrointestinal Haemorrhage
on Sep 08, 2010 Male patient from FRANCE , 70 years of age, was diagnosed with animal bite (What is animal bite?) and was treated with Aldactone (View Usage). Patient had the following side effects: gastrointestinal haemorrhage. Aldactone dosage: 75 Mg, Daily. During the same period patient was treated with PYOSTACINE (500 Mg, 2dfx3 A Day) (View Pyostacine Review and Pyostacine Label ), LASIX (20 Mg, Daily) (View Lasix Review and Lasix Label ), GARDENAL ^AVENTIS^ (100 Mg, 1x/day) (View Gardenal ^aventis^ Review and Gardenal ^aventis^ Label ), VITAMIN B1 AND B6 (2 Df, 3x/day) (View Vitamin B1 And B6 Review and Vitamin B1 And B6 Label ). Patient was hospitalized.

6989129-1 | Hyponatraemia, Hypotension
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hyponatraemia, hypotension on Aug 13, 2009 from FRANCE Additional patient health information: Female patient , weighting 104.7 lb, . Aldactone dosage: 75 Mg, 1x/day. During the same period patient was treated with LYRICA (50 Mg, 2x/day) (View Lyrica Review and Lyrica Label ), ZOLOFT (50 Mg, 1x/day) (View Zoloft Review and Zoloft Label ), IRBESARTAN (75 Mg, 1x/day) (View Irbesartan Review and Irbesartan Label ), NEXIUM (20 Mg, 1x/day) (View Nexium Review and Nexium Label ), ANAFRANIL (25 Mg, 1x/day) (View Anafranil Review and Anafranil Label ), CYMBALTA (30 Mg, 1x/day) (View Cymbalta Review and Cymbalta Label ), ZOLPIDEM (10 Mg, Unk) (View Zolpidem Review and Zolpidem Label ), FLECAINIDE ACETATE (50 Mg, 1x/day) (View Flecainide Acetate Review and Flecainide Acetate Label ). Patient was hospitalized.

6984548-1 | Anaemia
Adverse event was reported on Sep 07, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: Unk) was diagnosed with ascites, hepatitis c (What is hepatitis c?) and. Location: FRANCE , 54 years of age, Patient experienced the following unwanted or unexpected effects: anaemia. During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), INTERFERON (View Interferon Review and Interferon Label ), NEORAL (View Neoral Review and Neoral Label ), LASIX (View Lasix Review and Lasix Label ).

6976050-8 | Hepatic Encephalopathy
on Aug 31, 2010 Female patient from SPAIN , 56 years of age, was diagnosed with cirrhosis alcoholic, hypertension and was treated with Aldactone (View Usage). Patient had the following side effects: hepatic encephalopathy. Aldactone dosage: 100 Mg, Daily. During the same period patient was treated with REGULATEN (600 Mg, Daily) (View Regulaten Review and Regulaten Label ), SEGURIL (40 Mg, Daily) (View Seguril Review and Seguril Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Daily) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), HIDROXIL B12 B6 B1 (Unk) (View Hidroxil B12 B6 B1 Review and Hidroxil B12 B6 B1 Label ), SUMIAL (10 Mg, Daily) (View Sumial Review and Sumial Label ). Patient was hospitalized.

6967579-7 | Dysarthria, Hyperammonaemia, Somnolence
on Aug 26, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with ascites and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: dysarthria, hyperammonaemia, somnolence. Aldactone dosage: . During the same period patient was treated with TORASEMIDE (View Torasemide Review and Torasemide Label ), LASIX (View Lasix Review and Lasix Label ).

6958966-1 | Hepatic Encephalopathy
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy on Aug 20, 2010 from SPAIN Additional patient health information: Male patient , 72 years of age, . Aldactone dosage: 100 Mg, 1x/day. During the same period patient was treated with ENALAPRIL (20 Mg, 1x/day) (View Enalapril Review and Enalapril Label ), SEGURIL (80 Mg, 1x/day) (View Seguril Review and Seguril Label ), ACETYLSALICYLIC ACID (100 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), FLECAINIDE ACETATE (50 Mg, 1x/day) (View Flecainide Acetate Review and Flecainide Acetate Label ), SUMIAL (40 Mg, 1x/day) (View Sumial Review and Sumial Label ). Patient was hospitalized.

6958965-X | Atrioventricular Block Complete, Hyperkalaemia
Adverse event was reported on Aug 20, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 5 Mg, 1x/day) was diagnosed with cardiac failure, parkinson's disease (What is parkinson's disease?), gastritis atrophic, arthralgia and. Location: SPAIN , 93 years of age, Patient had the following side effects: atrioventricular block complete, hyperkalaemia. During the same period patient was treated with SINEMET (Unk) (View Sinemet Review and Sinemet Label ), OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), PARACETAMOL (2 G, 1x/day) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6958168-9 | Dermatitis Allergic, Eosinophilia, Pruritus, Rash, Urticaria
on Aug 19, 2010 Male patient from SWITZERLAND , 73 years of age, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: dermatitis allergic, eosinophilia, pruritus, rash (What is rash?), urticaria. Aldactone dosage: 50 Mg, 1x/day. During the same period patient was treated with TRAZODONE HCL (50 Mg, 1x/day) (View Trazodone Hcl Review and Trazodone Hcl Label ), ASPIRIN (50 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), BECOZYM (3 Tablets Daily) (View Becozym Review and Becozym Label ), BENERVA (300 Mg, 1x/day) (View Benerva Review and Benerva Label ), METFORMIN HYDROCHLORIDE (1000 Mg, 1x/day) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), REMERON (30 Mg, 1x/day) (View Remeron Review and Remeron Label ), SORTIS (20 Mg, 1x/day) (View Sortis Review and Sortis Label ), ATENOLOL (100 Mg, 1x/day) (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6958165-3 | Breast Swelling, Breast Tenderness, Mastitis
on Aug 19, 2010 Male patient from JAPAN , 76 years of age, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: breast swelling, breast tenderness, mastitis. Aldactone dosage: .

6936212-2 | International Normalised Ratio Increased, Prothrombin Level Decreased
Patient was taking Aldactone (View Usage). Patient had the following side effects: international normalised ratio increased, prothrombin level decreased on Aug 16, 2010 from FRANCE Additional patient health information: Male patient , 41 years of age, was diagnosed with anxiety (What is anxiety?), insomnia and. Aldactone dosage: 50 Mg, 1x/day. During the same period patient was treated with ATARAX (100 Mg, 1x/day) (View Atarax Review and Atarax Label ), METHADONE (1 Df, 1x/day) (View Methadone Review and Methadone Label ), IMOVANE (7.5 Mg, 1x/day) (View Imovane Review and Imovane Label ), PREVISCAN (20 Mg, 1x/day) (View Previscan Review and Previscan Label ), LASIX (Unk) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6931995-X | Hyperkalaemia, Renal Failure
Adverse event was reported on Aug 09, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: Dose:1 Unit(s)) . Location: ITALY , 78 years of age, After Aldactone was administered, patient had the following side effects: hyperkalaemia, renal failure. During the same period patient was treated with LASIX (Dose:4 Unit(s)) (View Lasix Review and Lasix Label ), COUMADIN (Dose:1 Unit(s)) (View Coumadin Review and Coumadin Label ), ENAPREN (Dose:2 Unit(s)) (View Enapren Review and Enapren Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), EUTIROX (View Eutirox Review and Eutirox Label ). Patient was hospitalized.

6925427-5 | Hypoglycaemia, Hyponatraemia, Hypotension
on Aug 06, 2010 Female patient from FRANCE , 89 years of age, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, hyponatraemia, hypotension. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with DIAMICRON (30 Mg, 3x/day) (View Diamicron Review and Diamicron Label ), BISOPROLOL (10 Mg, 1x/day) (View Bisoprolol Review and Bisoprolol Label ), BUMEX (5 Mg, 1x/day) (View Bumex Review and Bumex Label ), PERINDOPRIL ERBUMINE (5 Mg, 1x/day) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), PREVISCAN (20 Mg, Unk) (View Previscan Review and Previscan Label ), HEMIGOXINE NATIVELLE (0.125 Mg, 1x/day) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6925422-6 | Atrioventricular Block Complete, Hyperkalaemia, Renal Failure
on Aug 06, 2010 Male patient from FRANCE , 80 years of age, was diagnosed with cardiac failure, angina pectoris, hypertension and was treated with Aldactone (View Usage). Patient had the following side effects: atrioventricular block complete, hyperkalaemia, renal failure. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with BISOPROLOL FUMARATE (2.5 Mg, 1x/day) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), IVABRADINE (PROCORALAN) (5 Mg, 2x/day) (View Ivabradine (procoralan) Review and Ivabradine (procoralan) Label ), TRIATEC (5 Mg, 1x/day) (View Triatec Review and Triatec Label ), FUROSEMIDE (40 Mg) (View Furosemide Review and Furosemide Label ), ATORVASTATIN CALCIUM (20 Mg) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PREVISCAN (20 Mg) (View Previscan Review and Previscan Label ), CLARITIN (10 Mg) (View Claritin Review and Claritin Label ), DUPHALAC (2 Per Day) (View Duphalac Review and Duphalac Label ). Patient was hospitalized.

6923017-1 | Dermatitis Allergic, Eosinophilia, Pruritus, Rash
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: dermatitis allergic, eosinophilia, pruritus, rash (What is rash?) on Aug 04, 2010 from SWITZERLAND Additional patient health information: Male patient , 73 years of age, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia and. Aldactone dosage: 50 Mg, 1x/day. During the same period patient was treated with TRAZODONE HCL (50 Mg, 1x/day) (View Trazodone Hcl Review and Trazodone Hcl Label ), ASPIRIN (50 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), BECOZYM (3 Tablets Daily) (View Becozym Review and Becozym Label ), BENERVA (300 Mg, 1x/day) (View Benerva Review and Benerva Label ), METFORMIN HYDROCHLORIDE (1000 Mg, 1x/day) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), REMERON (30 Mg, 1x/day) (View Remeron Review and Remeron Label ), SORTIS (20 Mg, 1x/day) (View Sortis Review and Sortis Label ), ATENOLOL (100 Mg, 1x/day) (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6923004-3 | Confusional State
Adverse event was reported on Aug 04, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 25 Mg, 1x/day) was diagnosed with hypertension, back pain (What is back pain?) and. Location: SPAIN , 97 years of age, Patient experienced the following unwanted or unexpected effects: confusional state. During the same period patient was treated with LYRICA (Unk) (View Lyrica Review and Lyrica Label ), ENALAPRIL (Unk) (View Enalapril Review and Enalapril Label ), TRAMADOL (Unk) (View Tramadol Review and Tramadol Label ), MORPHINE HYDROCHLORIDE (Unk) (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ), KETESSE (Unk) (View Ketesse Review and Ketesse Label ). Patient was hospitalized.

6918853-1 | Bradycardia, Depressed Level Of Consciousness, Hyperhidrosis, Hypotension, Hypovolaemic Shock
on Aug 06, 2010 Male patient from ITALY , 91 years of age, was diagnosed with hypertension and was treated with Aldactone (View Usage). Patient had the following side effects: bradycardia, depressed level of consciousness, hyperhidrosis, hypotension, hypovolaemic shock. Aldactone dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), CLEXANE (View Clexane Review and Clexane Label ), PLAVIX (View Plavix Review and Plavix Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6914427-7 | Chromaturia
on Jul 29, 2010 Male patient from JAPAN , 96 years of age, was diagnosed with oedema and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: chromaturia. Aldactone dosage: 25 Mg, Daily. During the same period patient was treated with LASIX (Unk) (View Lasix Review and Lasix Label ), CLINORIL (Unk) (View Clinoril Review and Clinoril Label ), SELBEX (Unk) (View Selbex Review and Selbex Label ).

6900484-0 | Epistaxis, Renal Failure
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, renal failure on Jul 22, 2010 from FRANCE Additional patient health information: Female patient , 86 years of age, was diagnosed with hypertension and. Aldactone dosage: 25 Mg Per Day. During the same period patient was treated with LASIX (25 Mg, Single) (View Lasix Review and Lasix Label ), ESIDRIX (25 Mg, Single) (View Esidrix Review and Esidrix Label ), PRAZOSIN HCL (5 Mg) (View Prazosin Hcl Review and Prazosin Hcl Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ). Patient was hospitalized.

6900466-9 | Accidental Overdose, Bradycardia, Dehydration, Renal Function Test Abnormal
Adverse event was reported on Jul 22, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia, diabetes mellitus and. Location: FRANCE , 84 years of age, Patient had the following side effects: accidental overdose, bradycardia, dehydration, renal function test abnormal. During the same period patient was treated with LASIX (40 Mg, 1x/day) (View Lasix Review and Lasix Label ), HEMIGOXINE NATIVELLE (0.125 Mg, 1x/day) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), AMLOR (5 Mg, 1x/day) (View Amlor Review and Amlor Label ), AVODART (0.5 Mg, 1x/day) (View Avodart Review and Avodart Label ), LORAZEPAM (2.5 Mg, 1x/day) (View Lorazepam Review and Lorazepam Label ), NOVONORM (0.5 Mg, 2x/day) (View Novonorm Review and Novonorm Label ), SINTROM (Alternate Dosage 0.5 Or 0.75 Df Per Day) (View Sintrom Review and Sintrom Label ), ZOCOR (20 Mg, 1x/day) (View Zocor Review and Zocor Label ). Patient was hospitalized.

6895763-X | Hepatic Encephalopathy
on Jul 21, 2010 Male patient from SPAIN , 69 years of age, was diagnosed with chronic hepatitis and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hepatic encephalopathy. Aldactone dosage: 150 Mg, 1x/day. During the same period patient was treated with DEPRAX (100 Mg, 1x/day) (View Deprax Review and Deprax Label ), LANTANON (10 Mg, 1x/day) (View Lantanon Review and Lantanon Label ), SEGURIL (40 Mg, 1x/day) (View Seguril Review and Seguril Label ), DUPHALAC (30 Ml, 1x/day) (View Duphalac Review and Duphalac Label ), OMEPRAZOLE (40 Mg, Unk) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6894651-2 | Activated Partial Thromboplastin Time Prolonged, Anaemia, Candida Test Positive, Cheilitis, Haemorrhage, Hepatic Enzyme Increased, Hypoalbuminaemia, Hypoxia, Immunoglobulins Increased
on Jul 21, 2010 Male patient from JAPAN , 66 years of age, weighting 119.0 lb, was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, anaemia, candida test positive, cheilitis, haemorrhage, hepatic enzyme increased, hypoalbuminaemia, hypoxia, immunoglobulins increased. Aldactone dosage: . During the same period patient was treated with EVAMYL (View Evamyl Review and Evamyl Label ), EURODIN (View Eurodin Review and Eurodin Label ), SERENACE (View Serenace Review and Serenace Label ), TAGAMET HB (View Tagamet Hb Review and Tagamet Hb Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), OPALMON (View Opalmon Review and Opalmon Label ), LASIX (View Lasix Review and Lasix Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6887165-7 | Weight Decreased
Patient was taking Aldactone (View Usage). Patient had the following side effects: weight decreased on Jul 19, 2010 from FRANCE Additional patient health information: Female patient , 75 years of age, weighting 123.5 lb, . Aldactone dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6886833-0 | Thrombocytopenic Purpura
Adverse event was reported on Jul 19, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: Unk) was diagnosed with infection (What is infection?) and. Location: FRANCE , 83 years of age, After Aldactone was administered, patient had the following side effects: thrombocytopenic purpura. During the same period patient was treated with ROCEPHIN (Unk) (View Rocephin Review and Rocephin Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), LOVENOX (Unk) (View Lovenox Review and Lovenox Label ), SALBUTAMOL (Unk) (View Salbutamol Review and Salbutamol Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6876462-7 | Blood Creatinine Increased, Hyperkalaemia
on Jul 12, 2010 Female patient from SPAIN , 77 years of age, was diagnosed with hypothyroidism, type 2 diabetes mellitus, atrial fibrillation (What is atrial fibrillation?) and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, hyperkalaemia. Aldactone dosage: 12.5 Mg, 1x/day. During the same period patient was treated with AMLODIPINE,OLMESARTAN MEDOXOMIL (40/10 Mg, 1x/day) (View Amlodipine,olmesartan Medoxomil Review and Amlodipine,olmesartan Medoxomil Label ), OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), DEXNON (150 Mcg, 1x/day) (View Dexnon Review and Dexnon Label ), MIXTARD 30/70 ^NOVO NORDISK^ (View Mixtard 30/70 ^novo Nordisk^ Review and Mixtard 30/70 ^novo Nordisk^ Label ), LORAZEPAM (1 Mg, Unk) (View Lorazepam Review and Lorazepam Label ), SEGURIL (40 Mg, 1x/day) (View Seguril Review and Seguril Label ), SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6875683-7 | Chromaturia
on Jul 14, 2010 Male patient from JAPAN , 96 years of age, was diagnosed with oedema and was treated with Aldactone (View Usage). Patient had the following side effects: chromaturia. Aldactone dosage: 25 Mg, Daily. During the same period patient was treated with LASIX (Unk) (View Lasix Review and Lasix Label ), CLINORIL (Unk) (View Clinoril Review and Clinoril Label ), SELBEX (Unk) (View Selbex Review and Selbex Label ).

6863113-0 | Hyperkalaemia, Petechiae, Renal Failure
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hyperkalaemia, petechiae, renal failure on Jul 13, 2010 from ITALY Additional patient health information: Female patient , 78 years of age, . Aldactone dosage: Dose:1 Unit(s). During the same period patient was treated with LASIX (Dose:4 Unit(s)) (View Lasix Review and Lasix Label ), COUMADIN (Dose:1 Unit(s)) (View Coumadin Review and Coumadin Label ), ENAPREN (Dose:2 Unit(s)) (View Enapren Review and Enapren Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6847886-9 | Hepatic Encephalopathy
Adverse event was reported on Jul 06, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: 150 Mg, 1x/day) was diagnosed with chronic hepatitis and. Location: SPAIN , 69 years of age, Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy. During the same period patient was treated with TRAZODONE HCL (100 Mg, 1x/day) (View Trazodone Hcl Review and Trazodone Hcl Label ), LANTANON (10 Mg, 1x/day) (View Lantanon Review and Lantanon Label ), SEGURIL (40 Mg, 1x/day) (View Seguril Review and Seguril Label ), OMEPRAZOLE (40 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), DUPHALAC (30 Ml, 1x/day) (View Duphalac Review and Duphalac Label ). Patient was hospitalized.

6843954-6 | Chromaturia
on Jul 09, 2010 Male patient from JAPAN , 89 years of age, was treated with Aldactone (View Usage). Patient had the following side effects: chromaturia. Aldactone dosage: 25 Mg, 1x/day. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ).

6843613-X | Bradycardia, Depressed Level Of Consciousness, Hyperhidrosis, Hypotension, Hypovolaemic Shock
on Jul 08, 2010 Male patient from ITALY , 91 years of age, was diagnosed with hypertension and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: bradycardia, depressed level of consciousness, hyperhidrosis, hypotension, hypovolaemic shock. Aldactone dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), CLEXANE (View Clexane Review and Clexane Label ), PLAVIX (View Plavix Review and Plavix Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6826681-0 | Haematuria, Proteinuria, Renal Failure Acute
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: haematuria, proteinuria, renal failure acute on Jun 28, 2010 from FRANCE Additional patient health information: Female patient , 74 years of age, weighting 183.0 lb, was diagnosed with hypertension and. Aldactone dosage: . During the same period patient was treated with COVERSYL (4 Mg, 1x/day) (View Coversyl Review and Coversyl Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), VISKEN (View Visken Review and Visken Label ), LERCAN (View Lercan Review and Lercan Label ). Patient was hospitalized.

6826359-3 | Hyperkalaemia, International Normalised Ratio Increased, Renal Failure Acute
Adverse event was reported on Jun 29, 2010 by a Male patient taking Aldactone (View Usage) (Dosage: 100 Mg, 1x/day) . Location: SPAIN , 66 years of age, Patient had the following side effects: hyperkalaemia, international normalised ratio increased, renal failure acute. During the same period patient was treated with INSPRA (25 Mg, 1x/day) (View Inspra Review and Inspra Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), FUROSEMIDE (40 Mg, 3x/day) (View Furosemide Review and Furosemide Label ), ENALAPRIL (5 Mg, 1x/day) (View Enalapril Review and Enalapril Label ), SINTROM (Unk) (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6826284-8 | Hepatic Encephalopathy
on Jun 29, 2010 Male patient from SPAIN , 69 years of age, was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: hepatic encephalopathy. Aldactone dosage: 150 Mg, 1x/day. During the same period patient was treated with DEPRAX (100 Mg, 1x/day) (View Deprax Review and Deprax Label ), LANTANON (10 Mg, 1x/day) (View Lantanon Review and Lantanon Label ), SEGURIL (40 Mg, 1x/day) (View Seguril Review and Seguril Label ), DUPHALAC (30 Ml, 1x/day) (View Duphalac Review and Duphalac Label ), OMEPRAZOLE (40 Mg, Unk) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6826282-4 | Hepatic Encephalopathy
on Jun 29, 2010 Male patient from SPAIN , 51 years of age, was diagnosed with chronic hepatitis, prophylaxis and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy. Aldactone dosage: 100 Mg Daily. During the same period patient was treated with LORMETAZEPAM (2.5 Mg Daily) (View Lormetazepam Review and Lormetazepam Label ), FUROSEMIDE (20 Mg Daily) (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (20 Mg Daily) (View Omeprazole Review and Omeprazole Label ), PROPRANOLOL (40 Mg Daily) (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6817655-4 | Chromaturia
Patient was taking Aldactone (View Usage). Patient had the following side effects: chromaturia on Jun 24, 2010 from JAPAN Additional patient health information: Female patient , child 3 years of age, was diagnosed with oedema and. Aldactone dosage: 50 Mg, Daily. During the same period patient was treated with LASIX (125 Mg, Daily) (View Lasix Review and Lasix Label ).

6813271-9 | Arthritis, Dysphagia, Fall, Oropharyngeal Pain, Pruritus, Rash, Swollen Tongue, Vertigo, Weight Increased
Adverse event was reported on Jun 23, 2010 by a Female patient taking Aldactone (View Usage) (Dosage: 50 Mg, Daily) was diagnosed with hypertension and. Location: UNITED STATES , weighting 189.6 lb, After Aldactone was administered, patient had the following side effects: arthritis (What is arthritis?), dysphagia, fall (What is fall?), oropharyngeal pain, pruritus, rash (What is rash?), swollen tongue, vertigo, weight increased. During the same period patient was treated with ENALAPRIL (5 Mg, 2x/day) (View Enalapril Review and Enalapril Label ), TYLENOL (Unk) (View Tylenol Review and Tylenol Label ).

6812593-5 | Abdominal Pain Upper, Oesophageal Pain
on Jun 21, 2010 Female patient from BRAZIL , 50 years of age, was diagnosed with hypertension and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, oesophageal pain. Aldactone dosage: 12.5 Mg, 1x/day. During the same period patient was treated with DIAZEPAM (Unk) (View Diazepam Review and Diazepam Label ), NIFEDIPINE (Unk) (View Nifedipine Review and Nifedipine Label ), AMITRIPTYLINE (Unk) (View Amitriptyline Review and Amitriptyline Label ).

6808240-9 | Rash
on Apr 07, 2009 Female patient from UNITED STATES , weighting 128.0 lb, was treated with Aldactone (View Usage). Patient had the following side effects: rash (What is rash?). Aldactone dosage: 50 Mg, 2x/day.

6806961-5 | Dizziness, Fatigue, Muscle Spasms, Paraesthesia
Patient was taking Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, muscle spasms, paraesthesia on Jun 06, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 132.0 lb, was diagnosed with acne (What is acne?), off label use and. Aldactone dosage: .

6806687-8 | Breast Swelling
Adverse event was reported on Apr 15, 2008 by a Male patient taking Aldactone (View Usage) (Dosage: ) was diagnosed with myocardial infarction, cardiac disorder and. Location: UNITED STATES , weighting 167.0 lb, Patient experienced the following unwanted or unexpected effects: breast swelling. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), AVODART (View Avodart Review and Avodart Label ).

6806633-7 | Ill-defined Disorder
on Apr 04, 2008 Male patient from UNITED STATES , weighting 150.3 lb, was treated with Aldactone (View Usage). Patient had the following side effects: ill-defined disorder. Aldactone dosage: . During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ).

6806561-7 | Headache, Muscle Twitching, Presyncope, Vision Blurred
on Mar 04, 2008 Male patient from UNITED STATES , weighting 185.0 lb, was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: headache (What is headache?), muscle twitching, presyncope, vision blurred. Aldactone dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), POTASSIUM (View Potassium Review and Potassium Label ).

6806111-5 | Gynaecomastia, Sexual Dysfunction
Patient was taking Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: gynaecomastia, sexual dysfunction on Dec 18, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 200.0 lb, was diagnosed with polyuria and. Aldactone dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6805884-5 | Breast Enlargement, Erectile Dysfunction
Adverse event was reported on Jan 05, 2008 by a Male patient taking Aldactone (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, Patient had the following side effects: breast enlargement, erectile dysfunction (What is erectile dysfunction?).

6802561-1 | Abdominal Pain Upper, Arthritis, Breast Enlargement, Breast Pain, Feeling Abnormal, Malaise, Pain In Extremity, Pancreatitis, Somatisation Disorder
on Oct 19, 2008 Female patient from UNITED STATES , weighting 194.0 lb, was diagnosed with hypertension, arthritis (What is arthritis?), pain (What is pain?) and was treated with Aldactone (View Usage). After Aldactone was administered, patient had the following side effects: abdominal pain upper, arthritis (What is arthritis?), breast enlargement, breast pain, feeling abnormal, malaise, pain in extremity, pancreatitis, somatisation disorder. Aldactone dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), LOTREL (10/40) (View Lotrel Review and Lotrel Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6802069-3 | Eye Pain, Insomnia, Urticaria, Vision Blurred
on Aug 16, 2007 Female patient from UNITED STATES , weighting 121.3 lb, was diagnosed with acne (What is acne?), alopecia and was treated with Aldactone (View Usage). Patient experienced the following unwanted or unexpected effects: eye pain, insomnia, urticaria, vision blurred. Aldactone dosage: 1 Every Na Days.

6802060-7 | Pruritus
Patient was taking Aldactone (View Usage). Patient had the following side effects: pruritus on Aug 16, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with acne (What is acne?) and. Aldactone dosage: . During the same period patient was treated with FEMHRT (View Femhrt Review and Femhrt Label ).